Results 31 to 40 of about 38,934 (294)

Severe hypokalaemia in diabetic ketoacidosis: a contributor to central pontine myelinolysis?

Endocrinology, Diabetes & Metabolism Case Reports, 2019
Hypokalaemia at presentation of diabetic ketoacidosis is uncommon as insulin deficiency and metabolic acidosis shifts potassium extracellularly. However, hypokalaemia is a recognised complication of the management of diabetic ketoacidosis as insulin ...
A Chinoy, N B Wright, M Bone, R Padidela
doaj   +1 more source

Successful Treatment of Diabetic Ketoacidosis in a Patient with Insulin Allergy and Coronavirus Disease 2019: A Case Report

Endocrinology Research and Practice, 2022
Diabetic ketoacidosis is a frequent hyperglycemic emergency. During the coronavirus disease 2019 pandemic, researchers showed a higher prevalence of diabetic ketoacidosis and mortality compared with the preceding years.
Doğukan Şenberber, Mehmet Nuri Yakar, Dilan Delibalta, Tevfik Demir, Ali Necati Gökmen   +4 more
doaj  

Recurrent diabetic ketoacidosis

, 2019
Objective The purpose of this study is to examine risk factors for recurrence of diabetic ketoacidosis and determine interventions to prevent future admissions. Materials and methods Review article.
Evgenia Brandstaetter (7031165), Alan Jotkowitz (7031171), Leonid Barski (11881), Carmi Bartal (7031168), Iftach Sagy (3592385)   +4 more
core   +2 more sources

Recovery time of diabetic ketoacidosis in Africa: Systematic review and meta-analysis

Metabolism Open
Background: Diabetes mellitus is a long-term metabolic disease marked by consistently elevated blood glucose levels. Diabetic ketoacidosis is the medical consequence of diabetes mellitus that has the highest attributed fatality rate.
Tadios Lidetu, Simon Birhanu, Addisu Simachew Asgai, Tsegaamlak Kumelachew Derse, Yideg Abinew, Moges Tadesse, Desalegn Mitiku, Jemberu Chane, Banchamilak Adane, Tadele Kassahun Wudu, Betelhem Mekonnen, Desiyalew Habtamu Tamiru   +11 more
doaj   +1 more source

Clinical Profile of Diabetic Ketoacidosis: A Prospective Study in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2015
Background: Diabetic ketoacidosis, a well-known and major acute metabolic complication classically occurs in young patients with type 1 diabetes. However, it may occur in patients with type 2 Diabetes Mellitus too. Objective: Aim of this study was to
Pankaj Seth, Harpreet Kaur, Maneet Kaur
doaj   +1 more source

Risk factors for recurrent admissions with diabetic ketoacidosis: a case–control observational study

, 2016
To perform a detailed analysis of patients with recurrent diabetic ketoacidosis admissions in order to establish risk factors for readmission.The medical records of all adults and young people (> 15 years) with Type 1 diabetes admitted to Auckland City ...
Khanolkar, M, H. Cooper, Tekiteki, A, G. Braatvedt, M. Khanolkar, Cooper, H, Braatvedt, Geoffrey, A. Tekiteki   +7 more
core   +1 more source

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

Advanced Science, EarlyView.
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang, Yi Song, Changkun Li, Yuanyuan Luo, Mingwei Shao, Feng Guo, Fangyi Wei, Xunjie Fan, Wenwen Guo, Fengmei Xu, Yanhong Sang, Dongming Zhang, Yanhong Zhou, Lianwei Wang, Zhiqiang Kang, Yingjun Yang, Chunhua Song, Yanxia Liu, Xiaojun Ma, Jiao Wang, Chong Li, Shengnan Ma, Lin Zhao, Zhi Qin, Guolan Xing, Qiubo Zhao, Jun Li, Shumin Song, Dan Zhao, Ting Huang, Qingzhu Wang, Yanyan Zhao, Guijun Qin   +32 more
wiley   +1 more source

Evaluation of New-Onset Diabetes in Patients Presenting Emergency Service with a Diabetic Ketoacidosis Attack

, 2013
Aim: The aim of this study was to investigate the rate of new-onset diabetes mellitus (DM) in patients presenting to our emergency department with diabetic ketoacidosis. Methods: We retrospectively evaluated hospital records of patients who presented to
Emin Gökhan Gencer, Harun Ayhan, Doğaç Niyazi Özüçelik, Yavuz Yiğit, Mehmet Karakum   +4 more
core   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study

Pharmaceuticals, 2022
Dapagliflozin was associated with an increased risk of diabetic ketoacidosis that has led to the European withdrawal of the authorization for the type 1 diabetes. However, it is still used for the treatment of type 2 diabetes.
Gabriella di Mauro, Annamaria Mascolo, Mario Gaio, Concetta Rafaniello, Antonella De Angelis, Liberato Berrino, Giuseppe Paolisso, Francesco Rossi, Annalisa Capuano   +8 more
doaj   +1 more source